PageOverview.com
 

Websites, domains, hosts that links to general.takedapharm.com

Our database shows, that the website general.takedapharm.com is linked by a total of 11 websites.

 
Number of websites/domains displayed: 11
Results found: 11
 

Websites discovered:

COLCRYS (colchicine, USP) | Patient Information
http://pageoverview.com/website-report/colcrys.com
  • Expected expiration: December 18th in 2017
  • Creation date: December 18th in 2008
  • Renew date: October 18th in 2016
  • Google Analytics: 11126978-1
The NESINA Family - Learn About The Treatment Options
http://pageoverview.com/website-report/takedadiabetesadvantage.com
The NESINA Family are prescription medicines used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. Please see Important Safety Information, including boxed warnings.
  • Expected expiration: March 20th in 2018
  • Creation date: March 20th in 2013
  • Renew date: August 31st in 2017
  • Google Analytics: 40710438-6
Home | TRINTELLIX (vortioxetine)
http://pageoverview.com/website-report/brintellixhcp.com
TRINTELLIX (vortioxetine) is indicated for the treatment of major depressive disorder in adults. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a trend toward reduced risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber. TRINTELLIX has not been evaluated for use in pediatric patients.
  • Expected expiration: June 17th in 2018
  • Creation date: June 17th in 2013
  • Renew date: August 9th in 2017
  • Google Analytics: 35252106-2
Patient Information DEXILANT (dexlansoprazole)
http://pageoverview.com/website-report/dexilant.com
Product information on treatment with DEXILANT (dexlansoprazole) and resources to help you understand and manage your condition. See full safety and prescribing information.
  • Expected expiration: February 10th in 2018
  • Creation date: February 10th in 2010
  • Renew date: November 16th in 2016
  • Google Analytics: 5448303-4
ULORIC (febuxostat) | Patient Information
http://pageoverview.com/website-report/uloric.com
  • Expected expiration: May 9th in 2018
  • Creation date: May 9th in 2001
  • Renew date: February 22nd in 2017
  • Google Analytics: 6912318-1
ENTYVIO® (vedolizumab) | Patient Information
http://pageoverview.com/website-report/entyvio.com
Prescription medicine option when other treatments haven't worked well enough or can't be tolerated.
  • Expected expiration: July 12th in 2018
  • Creation date: July 12th in 2011
  • Renew date: March 31st in 2017
  • Google Analytics: 49842556-2
TRINTELLIX (vortioxetine) for U.S. Healthcare Professionals
http://pageoverview.com/website-report/trintellixhcp.com
Find TRINTELLIX (vortioxetine) dosing information, clinical study results, safety data, clinical pharmacology and savings information. See Important Safety Information and Prescribing Information.
  • Expected expiration: September 4th in 2018
  • Creation date: September 4th in 2015
  • Renew date: August 2nd in 2017
  • Google Analytics: 91996158-1
Home | Healthcare professionals | Entyvio (vedolizumab)
http://pageoverview.com/website-report/entyviohcp.com
Home | Information for healthcare professionals about Entyvio (vedolizumab), including indications, efficacy, and safety.
  • Expected expiration: November 27th in 2019
  • Creation date: November 27th in 2013
  • Renew date: November 28th in 2017
  • Google Analytics: 48857948-2
DEXILANT (dexlansoprazole) for U.S. Healthcare Professionals
http://pageoverview.com/website-report/dexilanthcp.com
Find DEXILANT (dexlansoprazole) dosing information, clinical data, safety data, and Instant Savings Card information. See Important Safety Information and Prescribing Information.
  • Expected expiration: June 29th in 2018
  • Creation date: June 29th in 2011
  • Renew date: February 22nd in 2017
  • Google Analytics: 29097032-1
Home | TRINTELLIX (vortioxetine)
http://pageoverview.com/website-report/trintellix.com
TRINTELLIX (vortioxetine) is indicated for the treatment of major depressive disorder in adults. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a trend toward reduced risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber. TRINTELLIX has not been evaluated for use in pediatric patients.
  • Expected expiration: July 10th in 2018
  • Creation date: July 10th in 2014
  • Renew date: May 8th in 2017
  • Google Analytics: 35252106-2
Patient Information | ROZEREM (ramelteon)
http://pageoverview.com/website-report/rozerem.com
ROZEREM (ramelteon) is approved for adults having trouble falling asleep from insomnia. Ask your doctor about ROZEREM. See Important Safety Information and Prescribing Information.
  • Expected expiration: February 25th in 2019
  • Creation date: February 25th in 2005
  • Renew date: October 11th in 2017
  • Google Analytics: 5275299-2
0.0282 // 2024-05-04 11:37:34
All Rights reserved 2018 © PageOverview.com